Snapshot from Jun 10, 2026 at 07:00 UTC. For live data and tracking: View Live
Events / Business / Regencell Bioscience Holdings...
Business securities fraud lawsuit

Regencell Bioscience Holdings securities fraud lawsuit

Analysis based on 11 articles · First reported Jun 01, 2026 · Last updated Jun 03, 2026

Sentiment
-50
Attention
4
Articles
11
Market Impact
Direct
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The market is impacted by the potential financial losses for investors of Regencell Bioscience Holdings due to alleged market manipulation and misleading statements. The lawsuit could lead to significant monetary and reputational harm for Regencell Bioscience Holdings, affecting its stock price and investor confidence.

Biotechnology Legal Services
Event Summary

Rosen Law Firm has filed a securities fraud class action lawsuit against Regencell Bioscience Holdings, alleging that the company made false and misleading statements to investors between October 28, 2024, and October 31, 2025. The lawsuit claims that Regencell Bioscience Holdings was vulnerable to market manipulation, leading to significant financial risk for its investors and exposing the company to regulatory scrutiny and reputational damage. Investors who purchased Regencell Bioscience Holdings securities during this period are encouraged to join the class action, with a lead plaintiff deadline set for June 23, 2026. Philip Kim and Lawrence Rosen of Rosen Law Firm are leading the efforts to represent affected investors.

Key Actions
100 Rosen Law Firm announces class action lawsuit Regencell Bioscience Holdings
90 Regencell Bioscience Holdings disclosed investigation
Entities Involved
stock
Regencell Bioscience Holdings
Regencell Bioscience Holdings is the defendant in a securities fraud class action lawsuit, facing allegations of market manipulation and misleading statements that exposed investors to significant financial risk and reputational harm.
Importance 100 Sentiment -70
priv
Rosen Law Firm
Rosen Law Firm is initiating and leading the securities fraud class action lawsuit against Regencell Bioscience Holdings, representing investors who suffered losses.
Importance 90 Sentiment 60
per
Philip Kim
Philip Kim, an attorney at Rosen Law Firm, is a contact person for investors interested in joining the class action lawsuit against Regencell Bioscience Holdings.
Importance 70 Sentiment 50
per
Lawrence Rosen
Lawrence Rosen, a founding partner of Rosen Law Firm, is highlighted for his firm's success in securities class actions, which is relevant to the ongoing lawsuit against Regencell Bioscience Holdings.
Importance 70 Sentiment 50
NEWSDESK
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.